43 completed, 4 active not recruiting, 4 terminated, 3 recruiting. 58 Phase 2, 12 Phase 1, 4 Phase 3.
Follow Poxviridae Infections: new trials by email Literature Review of Poxviridae Infections trials Research Report on Poxviridae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa BNT166a, Placebo - Mpox (Monkeypox), Smallpox | Phase 2 | Recruiting | BioNTech SE | 310 | 2026-02-20 | 2026-08-11 |
| Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo MVA-SIBP low dose, MVA-SIBP high dose, MVA-BN - Monkeypox (Mpox) | Phase 2 | Not yet recruiting | Shanghai Institute Of Biological Products | 180 | 2025-12-31 | 2025-11-28 |
| Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells Jynneos, MVA-BN (Quail) - Monkeypox (Mpox) | Phase 2 | Active not recruiting | Bavarian Nordic | 970 | 2025-10-27 | 2026-04-08 |
| An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC Mpox vaccination with MVA-BN - Mpox (Monkeypox) | Phase 2 | Active not recruiting | Institute of Tropical Medicine, Belgium | 600 | 2025-08-04 | 2026-11-18 |
| Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer Recombinant human IL-21-expressing oncolytic vaccinia virus injection - Advanced Pancreatic Cancer | Phase 2 | Recruiting | Hangzhou Converd Co., Ltd. | 12 | 2025-05-29 | 2026-02-27 |
| Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections MVA-BN - Monkeypox (Mpox) | Phase 2 | Active not recruiting | Bavarian Nordic | 460 | 2024-10-21 | 2025-11-24 |
| Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer Olvimulogene nanivacirepvec, Platinum chemotherapy: carboplatin or cisplatin, Non-platinum chemotherapy: paclitaxel or nab-paclitaxel for squamous cell NSCLC or pemetrexed for nonsquamous cell NSCLC - Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma | Phase 2 | Recruiting | Genelux Corporation | 142 | 2024-09-26 | 2026-06-04 |
| A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines BNT166a - Monkeypox | Phase 1 / Phase 2 | Completed | BioNTech SE | 96 | 2023-09-21 | 2026-09-15 |
| A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age mRNA-1769, Placebo - Smallpox, Mpox | Phase 1 / Phase 2 | Completed | ModernaTX, Inc. | 351 | 2023-08-15 | 2025-07-16 |
| A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox JYNNEOS - Monkeypox | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 450 | 2023-03-22 | 2026-03-27 |
| Tecovirimat for Treatment of Monkeypox Virus Tecovirimat Oral Capsule, Placebo - Monkeypox | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 597 | 2022-10-10 | 2025-10-09 |
| Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine JYNNEOS - Monkeypox | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 229 | 2022-09-09 | 2026-04-16 |
| Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS Tecovirimat, Smallpox and Mpox Vaccine, Placebo - Smallpox | Phase 2 | Active not recruiting | SIGA Technologies | 100 | 2022-04-05 | 2026-09-14 |
| Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years VAC∆6 vaccine (10⁷ PFU), VAC∆6 vaccine (10⁶ PFU), Live Smallpox Vaccine - Smallpox, Monkeypox | Phase 2 / Phase 3 | Completed | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 334 | 2021-10-01 | 2023-05-06 |
| A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors BT-001, Pembrolizumab [KEYTRUDA®] - Metastatic Cancer, Soft Tissue Sarcoma | Phase 1 / Phase 2 | Terminated | Transgene | 31 | 2021-02-25 | 2025-11-21 |
| FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues Immunohistochemical staining with anti-FOS - Colorectal Cancer, Monkey Pox | Phase 2 / Phase 3 | Unknown | xiaoliang Huang | 120 | 2020-12-01 | 2023-01-26 |
| A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC mFOLFOX6, MVA-BN-CV301, FPV-CV301 - Metastatic Colorectal Cancer | Phase 2 | Terminated | Patrick Boland | 17 | 2018-06-26 | 2025-07-22 |
| A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum SB206 4%, SB206 8%, SB206 12% - Molluscum Contagiosum | Phase 2 | Completed | Novan, Inc. | 256 | 2018-01-24 | 2023-05-06 |
| Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum. VP-102 with applicator - Molluscum Contagiosum | Phase 2 | Completed | Verrica Pharmaceuticals Inc. | 33 | 2017-06-08 | 2021-08-11 |
| A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum VBP-245 Topical Gel, Vehicle - Molluscum Contagiosum | Phase 2 | Completed | Veloce BioPharma LLC | 110 | 2017-02-27 | 2018-10-11 |
Showing 20 of 58. Sign in to see all of them.
Smallpox (31) · Mpox, Monkeypox (12) · Vaccinia (12) · Molluscum Contagiosum (7) · Neoplasms (4) · Carcinoma (3) · Colorectal Neoplasms (3) · Carcinoma, Hepatocellular (2) · Carcinoma, Non-Small-Cell Lung (2) · Cowpox (2) · Liver Neoplasms (2) · Melanoma (2) · Neoplasms by Histologic Type (2) · Ovarian Neoplasms (2)
DNA Virus Infections (58) · Infections (58) · Virus Diseases (57) · Animal Diseases (13) · Primate Diseases (12) · Rodent Diseases (12) · Neoplasms by Site (11) · Skin Diseases (10) · Skin and Connective Tissue Diseases (10) · Digestive System Diseases (8) · Digestive System Neoplasms (8) · Neoplasms (8) · Skin Diseases, Infectious (7) · Skin Diseases, Viral (6)
smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic (20) · Smallpox Vaccine (5) · DryVax vaccine (3) · tecovirimat (3) · Cantharidin (2) · Nivolumab (2) · 130-nm albumin-bound paclitaxel (1) · ACAM2000 (1) · Aventis Pasteur smallpox vaccine (1) · Bevacizumab (1) · Cisplatin (1) · Docetaxel (1) · Irinotecan (1) · Pemetrexed (1) · Sorafenib (1)
National Institute of Allergy and Infectious Diseases (NIAID) (14) · Bavarian Nordic (9) · Jennerex Biotherapeutics (3) · BioNTech SE (2) · Emergent BioSolutions (2) · Genelux Corporation (2) · SIGA Technologies (2) · Sanofi Pasteur, a Sanofi Company (2) · Andrea McCart (1) · Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" (1) · Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1) · Genelux GmbH (1) · Hangzhou Converd Co., Ltd. (1) · Institute of Tropical Medicine, Belgium (1) · ModernaTX, Inc. (1)
United States (36) · Democratic Republic of the Congo (4) · France (4) · Germany (4) · Canada (3) · South Korea (3) · China (2) · Puerto Rico (2) · Switzerland (2) · United Kingdom (2) · Belgium (1) · Hong Kong (1) · Mexico (1) · Russia (1) · South Africa (1)
James Burke, MD (2) · Richard N Greenberg, MD (2) · Daniel Oertli, M.D. (1) · David H Kirn, MD (1) · Dennis Hruby, Ph.D. (1) · Derek Jonker, MD (1) · Edgar T Overton, MD (1) · Erik Ross, MD (1) · Frank von Sonnenburg, Prof (1) · Gary Goldenberg, MD (1) · Giulio C Spagnoli, M.D. (1) · Helen MacKay, MD (1) · Hypolite Muhindo Mavoko (1)
PMID 36408618, PMID 11874634, PMID 14577912, PMID 19935776, PMID 19944151, PMID 20350190, PMID 20350191, PMID 20600480, PMID 21921208, PMID 22011376, PMID 23393196, PMID 23664987, PMID 25879867, PMID 26439129, PMID 27327616, PMID 28256358, PMID 29773661, PMID 31413923, PMID 32057574, PMID 33400412, PMID 33675226, PMID 37227734, PMID 38366591, PMID 40239067, PMID 41319397, PMID 42235570, PMID 42372625, PMID 42383154, PMID 42532635
U54AI057159 (1)